Medical Countermeasures U.S. Replenishes Smallpox and Mpox Vaccine Stockpile in $52.7 Million Contract AwardGlobal Biodefense StaffJune 29, 2026
Medical Countermeasures Smallpox Preparedness Contracts Top $60 Million as U.S. and International Partners Bolster Biodefense StockpilesGlobal Biodefense StaffMarch 25, 2026
Industry News U.S. Government Expands Smallpox Stockpile With $54 Million VIGIV Contract, International Orders Add $6.6 MillionGlobal Biodefense StaffMarch 25, 2026
Achaogen Gets Federal Funding for Biowarfare Agent Therapeutic Development Contracts + Grants October 9, 2017 …
First Plant-Based Seasonal Flu Vaccine Candidate Reaches Final Clinical Stage Industry News September 26, 2017 …
Pandemic Preparedness: Seqirus Quadruples Manufacturing Output for Flu Vaccine Industry News August 29, 2017 …
BARDA Awards 46M for Treatment System that Cleans Pathogens from Blood Contracts + Grants May 18, 2017 …
Emergent Unveils Expanded CIADM Facility for Medical Countermeasure Preparedness Biosecurity May 16, 2017 …
Soligenix Receives Japanese Patent for Vaccine Heat Stabilization Technology Industry News May 9, 2017 …
Battelle and Nanotherapeutics Form Alliance to Accelerate Medical Countermeasures Development CBRNE April 5, 2017 …
NIAID-Backed Phase 1b Study to Evaluate Broad-Spectrum Antiviral for Dengue Featured News February 1, 2017 …
PaxVax Announces Partnership with NIH and DOD for Chikungunya Vaccine Program Defense + Military January 10, 2017 …
MRIGlobal Awarded Contract for Mycobacterium Tuberculosis Quality Assessment Program Biodetection January 10, 2017 …